These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa. Thomi R; Yerly D; Yawalkar N; Simon D; Schlapbach C; Hunger RE Br J Dermatol; 2017 Nov; 177(5):1358-1366. PubMed ID: 28301691 [TBL] [Abstract][Full Text] [Related]
7. The P2X7 Receptor Is Overexpressed in the Lesional Skin of Subjects Affected by Hidradenitis Suppurativa: A Preliminary Study. Manfredini M; Giuliani AL; Ruina G; Gafà R; Bosi C; Zoppas E; Di Virgilio F; Bettoli V Dermatology; 2021; 237(1):111-118. PubMed ID: 31454821 [TBL] [Abstract][Full Text] [Related]
8. Serum Concentration and Skin Expression of S100A7 (Psoriasin) in Patients Suffering from Hidradenitis Suppurativa. Batycka-Baran A; Baran W; Nowicka-Suszko D; Koziol-Gałczyńska M; Bieniek A; Matusiak Ł; Łaczmański Ł; Szepietowski JC Dermatology; 2021; 237(5):733-739. PubMed ID: 33202403 [TBL] [Abstract][Full Text] [Related]
9. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa. Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG Inflammation; 2017 Apr; 40(2):464-472. PubMed ID: 28028756 [TBL] [Abstract][Full Text] [Related]
10. Primary alterations during the development of hidradenitis suppurativa. Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272 [TBL] [Abstract][Full Text] [Related]
11. Matrix remodelling and MMP expression/activation are associated with hidradenitis suppurativa skin inflammation. Sanchez J; Le Jan S; Muller C; François C; Renard Y; Durlach A; Bernard P; Reguiai Z; Antonicelli F Exp Dermatol; 2019 May; 28(5):593-600. PubMed ID: 30903721 [TBL] [Abstract][Full Text] [Related]
12. Keratinocyte-specific ablation of Mcpip1 impairs skin integrity and promotes local and systemic inflammation. Konieczny P; Lichawska-Cieslar A; Kwiecinska P; Cichy J; Pietrzycka R; Szukala W; Declercq W; Devos M; Paziewska A; Rumienczyk I; Kulecka M; Mikula M; Fu M; Borowczyk J; Santamaria-Babí LF; Jura J J Mol Med (Berl); 2019 Dec; 97(12):1669-1684. PubMed ID: 31786670 [TBL] [Abstract][Full Text] [Related]
13. Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies. Schell SL; Cong Z; Sennett ML; Gettle SL; Longenecker AL; Goldberg SR; Kirby JS; Helm MF; Nelson AM Br J Dermatol; 2023 Feb; 188(3):407-419. PubMed ID: 36680309 [TBL] [Abstract][Full Text] [Related]
14. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa. Emelianov VU; Bechara FG; Gläser R; Langan EA; Taungjaruwinai WM; Schröder JM; Meyer KC; Paus R Br J Dermatol; 2012 May; 166(5):1023-34. PubMed ID: 22136668 [TBL] [Abstract][Full Text] [Related]
15. Expression of innate defense antimicrobial peptides in hidradenitis suppurativa. Hofmann SC; Saborowski V; Lange S; Kern WV; Bruckner-Tuderman L; Rieg S J Am Acad Dermatol; 2012 Jun; 66(6):966-74. PubMed ID: 21982063 [TBL] [Abstract][Full Text] [Related]
16. Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers. Vossen ARJV; van der Zee HH; Davelaar N; Mus AMC; van Doorn MBA; Prens EP J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):761-765. PubMed ID: 30451329 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop. Hessam S; Sand M; Gambichler T; Skrygan M; Rüddel I; Bechara FG Br J Dermatol; 2018 Mar; 178(3):761-767. PubMed ID: 28975626 [TBL] [Abstract][Full Text] [Related]